Table 5.
Level | Success (n=97) | Failure (n=6) | OR (95% CI) | P-value |
---|---|---|---|---|
Type of TVT | ||||
TVT-O | 43 (44.3) | 4 (66.7) | Ref. | |
TVT-A | 54 (55.7) | 2 (33.3) | 3.21 (0.59, 17.40) | 0.175 |
Age | ||||
<60 years | 70 (72.1) | 4 (66.7) | Ref. | |
≥60 years | 27 (27.8) | 2 (33.3) | 0.98 (0.18, 5.35) | 0.980 |
BMI | ||||
<25 kg/m2 | 61 (62.9) | 4 (66.7) | Ref. | |
≥25 kg/m2 | 36 (37.1) | 2 (33.3) | 1.50 (0.28, 8.14) | 0.638 |
Parity | 2.20±1.04 | 2.14±0.90 | 1.05 (0.49, 2.27) | 0.891 |
Menopause | ||||
0 | 32 (33.0) | 2 (33.3) | Ref. | |
1 | 65 (67.0) | 4 (66.7) | 1.57 (0.33, 7.46) | 0.569 |
Menopause_MHT | ||||
Premenopause | 32 (33.0) | 2 (33.3) | Ref. | |
Menopause without MHT | 51 (52.6) | 3 (42.9) | 1.64 (0.31, 8.66) | 0.557 |
Menopause with MHT | 14 (14.4) | 1 (14.3) | 1.35 (0.13, 14.20) | 0.800 |
Values are presented as mean±standard deviation or number (%) unless otherwise indicated.
OR, odds ratio; CI, confidence interval; TVT; tension-free vaginal tape; TVT-O, TVT-obturator®; TVT-A, tension-free vaginal tape-Abbrevo; Ref., reference; BMI, body mass index; MHT, menopausal hormone therapy.